Infectious Complications in Laparoscopic Gynecologic Oncology Surgery within an ERAS-Compliant Setting
Minimally Invasive Surgery (MIS) represents a safe and feasible option for the surgical treatment of gynecologic malignancies, offering benefits, including reduced blood loss, lower complications, and faster recovery, without compromising oncological outcomes in selected patients. MIS is widely accepted in early-stage gynecologic malignancies, including endometrial cancer, cervical tumors measuring 2 cm or less, and early-stage ovarian cancer, considering the risk of surgical spillage. Despite its advantages, MIS does not rule out the possibility of adverse events such as postoperative infections. This retrospective study on 260 patients undergoing laparoscopic surgery at Parma University Hospital for gynecologic malignancies explores the incidence and risk factors of postoperative infectious complications. The Clavien-Dindo classification was used to rank postoperative surgical complications occurring 30 days after surgery and Enhanced Recovery After Surgery (ERAS) recommendations put into practice. In our population, 15 (5.8%) patients developed infectious complications, predominantly urinary tract infections (9, 3.5%). Longer surgical procedures were independently associated with higher postoperative infection risk (p = 0.045). Furthermore, C1 radical hysterectomy correlated significantly with infectious complications (p = 0.001, OR 3.977, 95% CI 1.370-11.544). In conclusion, compared to prior research, our study reported a lower rate of infectious complications occurrence and highlights the importance of adopting infection prevention measures.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Journal of personalized medicine - 14(2024), 2 vom: 29. Jan. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Capozzi, Vito Andrea [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 25.02.2024 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/jpm14020147 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368825647 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368825647 | ||
| 003 | DE-627 | ||
| 005 | 20240229151834.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/jpm14020147 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1305.xml |
| 035 | |a (DE-627)NLM368825647 | ||
| 035 | |a (NLM)38392581 | ||
| 035 | |a (PII)147 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Capozzi, Vito Andrea |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Infectious Complications in Laparoscopic Gynecologic Oncology Surgery within an ERAS-Compliant Setting |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 25.02.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Minimally Invasive Surgery (MIS) represents a safe and feasible option for the surgical treatment of gynecologic malignancies, offering benefits, including reduced blood loss, lower complications, and faster recovery, without compromising oncological outcomes in selected patients. MIS is widely accepted in early-stage gynecologic malignancies, including endometrial cancer, cervical tumors measuring 2 cm or less, and early-stage ovarian cancer, considering the risk of surgical spillage. Despite its advantages, MIS does not rule out the possibility of adverse events such as postoperative infections. This retrospective study on 260 patients undergoing laparoscopic surgery at Parma University Hospital for gynecologic malignancies explores the incidence and risk factors of postoperative infectious complications. The Clavien-Dindo classification was used to rank postoperative surgical complications occurring 30 days after surgery and Enhanced Recovery After Surgery (ERAS) recommendations put into practice. In our population, 15 (5.8%) patients developed infectious complications, predominantly urinary tract infections (9, 3.5%). Longer surgical procedures were independently associated with higher postoperative infection risk (p = 0.045). Furthermore, C1 radical hysterectomy correlated significantly with infectious complications (p = 0.001, OR 3.977, 95% CI 1.370-11.544). In conclusion, compared to prior research, our study reported a lower rate of infectious complications occurrence and highlights the importance of adopting infection prevention measures | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a enhanced recovery after surgery (ERAS) | |
| 650 | 4 | |a gynecologic malignancies | |
| 650 | 4 | |a gynecologic oncology | |
| 650 | 4 | |a infectious complications | |
| 650 | 4 | |a laparoscopic surgery | |
| 650 | 4 | |a minimally invasive surgery (MIS) | |
| 650 | 4 | |a morbidity prevention | |
| 650 | 4 | |a postoperative complications | |
| 700 | 1 | |a De Finis, Alessandra |e verfasserin |4 aut | |
| 700 | 1 | |a Scarpelli, Elisa |e verfasserin |4 aut | |
| 700 | 1 | |a Gallinelli, Asya |e verfasserin |4 aut | |
| 700 | 1 | |a Monfardini, Luciano |e verfasserin |4 aut | |
| 700 | 1 | |a Cianci, Stefano |e verfasserin |4 aut | |
| 700 | 1 | |a Gulino, Ferdinando Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Rotondella, Isabella |e verfasserin |4 aut | |
| 700 | 1 | |a Celora, Gabriella Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Martignon, Giulia |e verfasserin |4 aut | |
| 700 | 1 | |a Ghi, Tullio |e verfasserin |4 aut | |
| 700 | 1 | |a Berretta, Roberto |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of personalized medicine |d 2011 |g 14(2024), 2 vom: 29. Jan. |w (DE-627)NLM228113881 |x 2075-4426 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2024 |g number:2 |g day:29 |g month:01 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/jpm14020147 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2024 |e 2 |b 29 |c 01 | ||